Plastic Surgery
Audio Summaries

Syncope

This article by Rose Anne Kenny addresses the clinical problem of syncope, which is characterized by transient cerebral hypoperfusion and can arise from various mechanisms such as reflex, orthostatic, and cardiac causes. The authors emphasize the importance of accurate diagnosis through thorough history taking, physical examination, and risk stratification to guide targeted testing and management strategies aimed at reducing recurrence and injury risk, particularly in older patients where syncope may present as unexplained falls. The study highlights the necessity of early identification of high-risk features to prevent adverse cardiovascular outcomes.

Phase 2b Trial of a Na_V1.8 Inhibitor for Acute Pain

The authors aimed to evaluate the efficacy of LTG-001, a selective Na_v1.8 inhibitor, in reducing moderate-to-severe pain following abdominoplasty compared to placebo and hydrocodone bitartrate-acetaminophen. The results indicated that high-dose LTG-001 significantly reduced pain scores and opioid consumption compared to placebo, demonstrating its potential as an effective treatment for acute pain management. However, the high-dose group also experienced a higher incidence of certain side effects, such as pyrexia and presyncope.

Antiretroviral Therapy

This article by Roy M Gulick reviews the advancements in antiretroviral therapy (ART) for HIV infection, focusing on the effectiveness of various drug classes in suppressing viral replication and improving patient outcomes. The authors aim to highlight the importance of ART in enhancing immune function, reducing morbidity and mortality, and preventing transmission, ultimately demonstrating that individuals on ART can achieve life expectancies comparable to the general population. The article also discusses the ongoing monitoring and adaptation of treatment regimens based on patient response and resistance testing.

Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer

This study investigates the efficacy and safety of perioperative enfortumab vedotin combined with pembrolizumab compared to standard neoadjuvant cisplatin-gemcitabine chemotherapy in patients with muscle-invasive bladder cancer eligible for cisplatin-based treatment. The results indicate that the enfortumab vedotin-pembrolizumab regimen significantly improves event-free survival, overall survival, and rates of pathological complete response, although it is associated with a higher incidence of severe adverse events.

Health Care-Associated Infections in U.S. Hospitals, 2023 versus 2015

The authors aimed to assess changes in the prevalence of health care-associated infections (HAIs) in U.S. hospitals by comparing data from 2023 to previous surveys conducted in 2015. Their findings indicate a decrease in the prevalence of HAIs, with 2.6% of patients affected in 2023 compared to 3.2% in 2015, although the overall burden remains significant, with an estimated 518,000 HAIs in U.S. hospitals in 2023. Notably, a majority of these infections were not linked to medical devices or procedures.

Fibromyalgia

The authors explore the characteristics and management of fibromyalgia, a condition marked by widespread pain, fatigue, and cognitive issues, often coexisting with other chronic pain disorders. They emphasize the role of the central nervous system in the condition's hyperresponsiveness to sensory stimuli and discuss how effective treatments aim to restore CNS balance. While fibromyalgia is rarely curable, the authors highlight that it can typically be managed effectively within primary care settings.

Andes Virus - A Clinical Review

The authors aim to provide a comprehensive overview of Andes virus (ANDV), focusing on its epidemiology, clinical features, and management strategies. They evaluate current and investigational treatments, including antiviral agents and monoclonal antibody therapies, while also discussing vaccine development and essential infection prevention measures. This review serves to inform clinical practice and enhance understanding of ANDV's impact on public health.

Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma

This phase 3 trial aimed to determine whether indefinite-duration maintenance therapy with lenalidomide leads to better overall survival compared to fixed-duration therapy (2 years) in patients with standard-risk newly diagnosed multiple myeloma not receiving up-front autologous stem-cell transplantation. The results showed no significant difference in overall survival between the two groups, although progression-free survival was slightly better in the indefinite-duration group. Additionally, the indefinite-duration therapy was associated with a higher incidence of adverse events.

Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease

The authors aimed to determine whether extending dual antiplatelet therapy (DAPT) beyond 12 months benefits event-free patients with multivessel coronary artery disease after stenting. In a randomized trial involving 8,250 patients, they found that extending DAPT reduced the risk of cardiovascular events compared to aspirin monotherapy, without increasing bleeding risks.

Platelet-Activating Anti-Platelet Factor 4 Disorders

This paper explores the mechanisms and clinical implications of platelet-activating antibodies against platelet factor 4 (PF4), which lead to prothrombotic disorders such as heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT). The authors aim to clarify the distinct characteristics of these disorders, including their autoimmune variants and the role of specific genetic mutations in antibody formation, while emphasizing the importance of accurate diagnostic assays and potential therapeutic strategies beyond anticoagulation.